Anthrax — Precision Vaccinations

Fact checked by Robert Carlson, MD

May 17

3 min read

BARDA to Purchase Anthrax Vaccine for Strategic Stockpile

Emergent Anthrax Vaccine AV7909 consists of Anthrax Vaccine Adsorbed drug substance and CPG 7909 adjuvant

terror training

Clinical Trials

Fact checked by Robert Carlson, MD

May 3

2 min read

Therapeutic Anthrax Vaccine Candidate Launches Phase 3 Study

AV7909 vaccine is being developed for post-exposure prophylaxis of disease resulting from Bacillus anthracis exposure

microscope in a lab

Fact checked by Robert Carlson, MD

Jan 2

4 min read

3rd Generation Anthrax Vaccine Moves Forward

Emergent BioSolutions NuThrax anthrax vaccine adsorbed with CPG 7909 Adjuvant is being studied for use as a third-generation anthrax vaccine

New york city

Fact checked by Robert Carlson, MD

Dec 19

4 min read

Anthrax Vaccine BioThrax Expands Into Canada

Emergent BioSolutions anthrax vaccine BioThrax now approved for Canada

cows, bovines

Fact checked by Robert Carlson, MD

Oct 17

3 min read

Dual Protection Vaccine Candidate Against Anthrax & Plague Advances

T4 nanoparticle is a novel platform for developing multivalent vaccines against pathogens of high public health concern

army soldiers putting on gas masks